Insider trades
Andrew J. Schwab, Director of Skye Bioscience SKYE, has filed 2 purchases and 35 sales on the open market. Over the past 12 months that comes to a net sale of $2M. The latest trade was on 09/23.
Andrew J. Schwab
Director
- Company
- Skye Bioscience SKYE
- First filing
- 23/02/28
- Trades
- 72 trades
- Buys / sales
- 2 / 35
- 12-month net buying
- −$2M
- Last trade
- 09/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
SKYE | Open-market sale | 09/22–09/23 | 09/24 | 148,079 sh4 trades | $1.62avg. | $239,555.19 | −100.0% |
| Open-market sale | 25/11/14 | 25/11/18 | 200,000 sh | $8.80 | $1,760,000 | −6.3% | |
SKYE | Open-market sale | 25/08/21–25/08/22 | 25/08/22 | 231,405 sh4 trades | $3.46avg. | $800,548.5 | −80.1% |
TRDA | Open-market sale | 25/07/09 | 25/07/11 | 27,000 sh2 trades | $7.50avg. | $202,500 | No record |
TRDA | Open-market sale | 25/06/27–25/07/01 | 25/07/01 | 125,000 sh6 trades | $6.93avg. | $866,500 | No record |
| Open-market buy | 24/10/15 | 24/10/15 | 909,090 sh | $11.00 | $9,999,990 | +53.0% | |
SKYE | Open-market sale | 24/09/11–24/09/13 | 24/09/13 | 266,337 sh6 trades | $6.57avg. | $1,750,352.22 | −80.1% |
| Open-market buy | 24/07/22 | 24/07/24 | 833,333 sh | $12.00 | $9,999,996 | +239.0% | |
ELVN | Open-market sale | 24/02/14 | 24/02/16 | 825,000 sh2 trades | $14.90avg. | $12,292,500 | −56.5% |
ELVN | Open-market sale | 24/01/31 | 24/02/02 | 500,000 sh2 trades | $15.00avg. | $7,500,000 | −39.3% |
ELVN | Open-market sale | 23/09/26 | 23/09/28 | 197,500 sh2 trades | $15.00avg. | $2,962,500 | −18.8% |
ELVN | Open-market sale | 23/08/24 | 23/08/28 | 440,000 sh2 trades | $16.00avg. | $7,040,000 | −33.1% |
| Open-market sale | 23/04/10 | 23/04/12 | 16,544,113 sh3 trades | $0.12avg. | $1,985,293.56 | −98.8% | |
RallybioRLYB | Open-market sale | 23/03/07 | 23/03/09 | 100,000 sh | $8.20 | $820,000 | −4.0% |
